Rosalind Advisors, Inc. 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-08-14 7:15 pm Purchase | 2024-07-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 6,970,425 9.900% | 2,977,839 (+74.58%) | Filing |
| 2024-07-11 5:37 pm Unchanged | 2024-06-28 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 3,992,586 9.900% | 0 (Unchanged) | Filing |
| 2024-04-25 8:01 pm Sale | 2024-03-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 3,992,586 9.900% | -2,684,347 (-40.20%) | Filing |
| 2024-02-14 8:31 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 6,676,933 9.900% | 4,518,661 (+209.36%) | Filing |
| 2023-02-13 5:53 pm Unchanged | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 2,158,272 9.970% | 0 (Unchanged) | Filing |
| 2022-11-02 8:03 pm Purchase | 2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 2,158,272 9.970% | 1,553,044 (+256.60%) | Filing |
| 2022-01-21 3:49 pm Purchase | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 605,228 9.970% | 284,512 (+88.71%) | Filing |
| 2021-07-08 1:30 pm Purchase | 2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors, Inc. | 320,716 6.000% | 320,716 (New Position) | Filing |